immunotoxin


Also found in: Dictionary, Thesaurus, Medical, Financial, Wikipedia.

immunotoxin

[‚im·yə·nō′täk·sən]
(immunology)
Conjugate of antibody and toxic protein such that the specificity of the antibody molecule is combined with the cytotoxic property of the toxin.
References in periodicals archive ?
Chertov et al., "A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity," Blood, vol.
Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression.
Pastan, "Immunotoxin and Taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumors," Proceedings of the National Acadamy of Sciences of the United States of America, vol.
In the present study, we reported the novel immunotoxin PT by fusing the scFv of Pan to 38 kDa truncated fragment of PE and investigated its potent antitumor potency against esophageal cancer cells in vitro and in vivo.
[sup][14] first reported a novel immunotoxin that could kill cancer cells.
In order to determine whether all damages to ipRGCs were caused by the injection of immunotoxin, or whether theses damages were also potentially related with age, we immunohistochemically labeled ipRGCs using antibodies against melanopsin and compared the number of ipRGCs on flat-mounted retina among 1-, 3-, and 6-month-old rd mice (n = 6 in each age group) (the detailed methodology is described below).
A multicenter, randomized, open-label Phase II study is currently ongoing in patients with recurrent GBM to evaluate efficacy of intratumoral administration of cpIL-4PE after surgical resection, with a secondary objective to evaluate safety and tolerability of this immunotoxin (NCT00014677).
Solicitation: Production Of Pegylated Immunotoxin For Pre-Clinical Cancer Studies
(2000) Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity.
Stirpe, "T lymphocyte killing by a xanthine-oxidase-containing immunotoxin," Cancer Immunology, Immunotherapy, vol.
Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas.
Half of the animals subsequently received a two-week dose of a genetically designed, HIV-specific poison, or immunotoxin, to complement the antiretrovirals, while the other half continued receiving antiretrovirals alone.